Federal government under fire for stopping short of U.S. commitment on vaccine waiver
WASHINGTON — Ottawa has yet to follow the United States on easing patent protections for COVID-19 vaccines — and critics and allies alike are noticing.
The One Campaign, a progressive anti-poverty group that has praised Justin Trudeau in the past, calls Canada “oddly absent” from the discussion.
The U.S. agreed Wednesday to so-called text-based negotiations at the World Trade Organization on a possible waiver to the rules.
The idea is to make vaccine formulas and expertise more widely available so more countries could develop their own supply.